Palliative Care Social Work State of the Science (SA303A)

in hospice patients is the goal of this session.An expert panel of palliative care physicians, hematologists, and pharmacotherapy specialists will present cases and didactic material, and engage the audience with the following goals: 1) Discuss the mechanisms of action of currently available anticoagulants; 2) Discuss the quality-of-life benefits associated with using anticoagulants in the hospice population; 3) Recognize potential drug interactions between anticoagulants and other prescribed medications at the end of life; 4) Recognize bleeding risk and learn how to manage bleeding associated with using anticoagulants at the end of life; 5) Discuss communication approaches with patients and family when deprescribing anticoagulants; and 6) Determine the optimal anticoagulant based on prognosis.